Cited by 55Smoking Behavior and CessationChronic Obstructive Pulmonary Disease (COPD) ResearchLipoproteins and Cardiovascular Health

A Pilot Study To Examine the Effects of Smoking Cessation on Serum Markers of Inflammation in Women at Risk for Cardiovascular Disease

Open access
Reichert, Virginia, Xue, Xiangying, Bartscherer, Diane, Jacobsen, Daniel, Fardellone, Christine, Folan, Patricia, Kohn, Nina, Talwar, Arunabh +1 more·2009·Chest

Abstract

Background The links among smoking, inflammation, and cardiovascular disease (CVD) are well established. Several studies have demonstrated that quitting smoking reverses the risk of coronary heart disease within 5 to 10 years. However, the immediate effects of quitting smoking on inflammatory biomarkers associated with CVD risk have not been well described.Methods In this pilot study, we examined a panel of circulating inflammatory biomarkers associated with CVD in "at-risk" women during the smoking cessation program. Forty-six women enrolled in a smoking cessation program consented to attend four study visits over 6 to 7 weeks. Health/medical information and blood were collected at each visit. Circulating levels of C-reactive protein (CRP), tumor necrosis factor (TNF), interleukin (IL)-6, soluble TNF receptor (sTNFR)-I, sTNFR-II, and soluble vascular cell adhesion molecule (sVCAM)-1 were measured, and changes between baseline levels (visit 1, while smoking) and visits 2 through 4 were determined.Results Significant reductions in circulating levels of TNF, sTNFR-I, sTNFR-II, and sVCAM-1 were observed among participants over the course of the smoking cessation program. Serum levels of both IL-6 and CRP declined during the smoking cessation program; the changes were not statistically significant, however.Conclusions These findings suggest there are rapid consequences of smoking cessation on inflammatory biomarkers in women at risk for CVD. Additional, larger studies including diverse smokers desiring to quit are required to confirm changes in "measurable milestones" that could serve as motivating factors to assist smokers to quit.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1378/chest.08-2288

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Reichert, V., Xue, X., Bartscherer, D., Jacobsen, D., Fardellone, C., Folan, P., Kohn, N., Talwar, A., & Metz, C. N.
Affiliations
Northwell Health (US)
Corresponding author
Metz, Christine N.
Venue
Chest
Publisher
Elsevier BV
Published
2009-07
Volume
136
Issue
1
Pages
212-219
ISSN
0012-3692 (ISSN-L)
OpenAlex
W2041506422
Cited by
55
References
53
Citations by year
2026: 2 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 1 · 2015: 3 · 2014: 7 · 2013: 3 · 2012: 3
FWCI
2.43
Type
journal article
Language
en
Open access
Locations
  • CHEST Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pfizer
  • National Institute of General Medical Sciences (R01GM070727)
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
smoking cessation, inflammation, cardiovascular risk, women, C-reactive protein, TNF-α, interleukin-6, soluble TNF receptors, soluble vascular cell adhesion molecule, inflammatory markers, smoking cessation interventions
MeSH terms
Adult, Aged, C-Reactive Protein, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Middle Aged, Pilot Projects, Risk Factors, Cohort Studies, Interleukin-6, Smoking Cessation, Receptors, Tumor Necrosis Factor, Inflammation Mediators, Vascular Cell Adhesion Molecule-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review